HealthCor Management »

Alnylam Pharmaceuticals shares owned by HealthCor Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by HealthCor Management from 13F filings

Historical chart of HealthCor Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by HealthCor Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by HealthCor Management

Quarter filed Position value Share count Share price at filing
2011-06-30 $17M 1.8M 9.37

More positions owned by HealthCor Management

Aetna
Quest Diagnostics Incorporated (DGX)
Stryker Corporation (SYK)
Magellan Health Services
Allscripts Healthcare Solutions (MDRX)
Covidien
Universal Health Services (UHS)
Cardinal Health (CAH)
DaVita (DVA)
Humana (HUM)
CIGNA Corporation
PerkinElmer (RVTY)
Salix Pharmaceuticals
Sirona Dental Systems
Cubist Pharmaceuticals

View all positions for HealthCor Management

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
Vanguard Group
BlackRock
BlackRock
Capital Research Global Investors
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies
Groupama Asset Managment

View all funds holding Alnylam Pharmaceuticals